Nath Bio-Genes (India) Limited Share Price Bombay S.E.
Equities
NATHBIOGEN
INE448G01010
Fishing & Farming
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
207.2 INR | +3.83% | +8.45% | -0.07% |
01-18 | Nath Bio-Genes Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
2023 | Transcript : Nath Bio-Genes Limited, Q2 2024 Earnings Call, Oct 17, 2023 |
Sales 2022 | 2.78B 33.39M 2.67B | Sales 2023 | 3.01B 36.15M 2.89B | Capitalization | 2.68B 32.2M 2.58B |
---|---|---|---|---|---|
Net income 2022 | -673M -8.07M -646M | Net income 2023 | 350M 4.2M 336M | EV / Sales 2022 | 1.78 x |
Net Debt 2022 | 888M 10.65M 853M | Net Debt 2023 | 672M 8.06M 646M | EV / Sales 2023 | 1.11 x |
P/E ratio 2022 |
-6.02
x | P/E ratio 2023 |
7.67
x | Employees | 433 |
Yield 2022 |
0.94% | Yield 2023 |
1.42% | Free-Float | 38.47% |
Latest transcript on Nath Bio-Genes (India) Limited
1 day | +3.83% | ||
1 week | +8.45% | ||
Current month | +19.25% | ||
1 month | +17.13% | ||
3 months | -4.93% | ||
6 months | +11.64% | ||
Current year | -0.07% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 64 | 29/08/99 | |
Director of Finance/CFO | 63 | - | |
Compliance Officer | 30 | 30/07/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 64 | 29/08/99 | |
Director/Board Member | 60 | 09/10/12 | |
Director/Board Member | 42 | 29/03/15 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 207.2 | +3.83% | 8,717 |
25/04/24 | 199.6 | +0.33% | 877 |
24/04/24 | 198.9 | -0.82% | 2,765 |
23/04/24 | 200.6 | +1.19% | 2,542 |
22/04/24 | 198.2 | +3.74% | 5,788 |
Delayed Quote Bombay S.E., April 26, 2024 at 11:21 am
More quotes1st Jan change | Capi. | |
---|---|---|
+12.78% | 3.29B | |
-95.58% | 1.61B | |
-0.48% | 1.61B | |
-2.37% | 1.25B | |
-2.40% | 1.22B | |
-.--% | 1.22B | |
-11.54% | 1.21B | |
-10.44% | 1.2B | |
0.00% | 1.19B |
- Stock Market
- Equities
- NATHBIOGEN Stock
- NATHBIOGEN Stock